Lv44
588 积分 2024-02-27 加入
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease
3天前
已完结
Hyperhomocysteinemia is linked to MASLD
22天前
已完结
MAFLD vs. MASLD: Consensus is unlike evidence!
22天前
已完结
Lean MASLD: are overweight or obese people with MASLD ‘protected’ from CVD mortality?
22天前
已完结
Metabolic Divergence Between MASLD and Metabolic Syndrome: Distinct Clinical Phenotypes and Risk Stratification Implications
22天前
已完结
Subtypes of MASLD confer distinct clinical trajectories
22天前
已完结
The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?
1个月前
已完结
Liver metabolism in human MASLD: A review of recent advancements using human tissue metabolomics
1个月前
已完结
MASLD Risk Score (MRS) and Random Forest model (RF Model): Novel tools for screening and severity assessment of MASLD
1个月前
已完结
Subtypes of MASLD confer distinct clinical trajectories
1个月前
已完结
皖公网安备34019202002308
